NCT05523765 - A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 14, 2022

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions

Non-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Pan Uveitis

Interventions

DRUG

Brepocitinib

Oral Brepocitinib

Trial Locations (15)

Clinical Trial Site, Winston-Salem

Clinical Trial Site, Durham

Clinical Trial Site, Nashville

Clinical Trial Site, St Louis

Clinical Trial Site, Plano

Clinical Trial Site, Bellaire

Clinical Trial Site, Katy

Clinical Trial Site, Lakewood

Clinical Trial Site, Salt Lake City

Clinical Trial Site, Los Angeles

Clinical Trial Site, Pasadena

Clinical Trial Site, Palo Alto

Clinical Trial Site, Eugene

Clinical Trial Site, Waltham

Clinical Trial Site, Palisades Park